Cargando…

Outcomes on home haemodialysis: registry challenges

Health care policy is encouraging expansion of home haemodialysis, aiming to improve patient outcomes and reduce cost. However, most patient outcome data derive from retrospective observational studies, with all their inherent weaknesses. Conventional thrice weekly home haemodialysis delivers a 22–5...

Descripción completa

Detalles Bibliográficos
Autor principal: MacGregor, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421466/
https://www.ncbi.nlm.nih.gov/pubmed/25949517
http://dx.doi.org/10.1093/ndtplus/sfr126
_version_ 1782369875714375680
author MacGregor, Mark S.
author_facet MacGregor, Mark S.
author_sort MacGregor, Mark S.
collection PubMed
description Health care policy is encouraging expansion of home haemodialysis, aiming to improve patient outcomes and reduce cost. However, most patient outcome data derive from retrospective observational studies, with all their inherent weaknesses. Conventional thrice weekly home haemodialysis delivers a 22–51% reduction in mortality, but why should that be? Frequent and/or nocturnal haemodialysis reduces mortality by 36–66%, with comparable outcomes to deceased donor kidney transplantation. Approaches which might improve the quality of future observational studies are discussed. Patient-relevant outcomes other than mortality are also discussed.
format Online
Article
Text
id pubmed-4421466
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44214662015-05-06 Outcomes on home haemodialysis: registry challenges MacGregor, Mark S. NDT Plus Articles Health care policy is encouraging expansion of home haemodialysis, aiming to improve patient outcomes and reduce cost. However, most patient outcome data derive from retrospective observational studies, with all their inherent weaknesses. Conventional thrice weekly home haemodialysis delivers a 22–51% reduction in mortality, but why should that be? Frequent and/or nocturnal haemodialysis reduces mortality by 36–66%, with comparable outcomes to deceased donor kidney transplantation. Approaches which might improve the quality of future observational studies are discussed. Patient-relevant outcomes other than mortality are also discussed. Oxford University Press 2011-12 /pmc/articles/PMC4421466/ /pubmed/25949517 http://dx.doi.org/10.1093/ndtplus/sfr126 Text en © The Author 2011. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Articles
MacGregor, Mark S.
Outcomes on home haemodialysis: registry challenges
title Outcomes on home haemodialysis: registry challenges
title_full Outcomes on home haemodialysis: registry challenges
title_fullStr Outcomes on home haemodialysis: registry challenges
title_full_unstemmed Outcomes on home haemodialysis: registry challenges
title_short Outcomes on home haemodialysis: registry challenges
title_sort outcomes on home haemodialysis: registry challenges
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421466/
https://www.ncbi.nlm.nih.gov/pubmed/25949517
http://dx.doi.org/10.1093/ndtplus/sfr126
work_keys_str_mv AT macgregormarks outcomesonhomehaemodialysisregistrychallenges